In vitro enzyme inhibitory effects of green and brown Australian seaweeds and potential impact on metabolic syndrome

被引:3
|
作者
Shannon, Emer [1 ,2 ]
Conlon, Michael [2 ]
Hayes, Maria [1 ]
机构
[1] Teagasc Food Res Ctr, Food Biosci Dept, Dublin 15, Ireland
[2] Commonwealth Sci & Ind Res Org, Hlth & Biosecur, Adelaide, SA 5000, Australia
关键词
Metabolic syndrome; Seaweeds; ACE-1; inhibition; alpha-amylase inhibition; Lipase inhibition; Functional food development; ASSISTED HYDROTHERMAL EXTRACTION; RENIN-ANGIOTENSIN SYSTEM; ASCOPHYLLUM-NODOSUM; ECKLONIA-CAVA; UNDARIA-PINNATIFIDA; ALPHA-AMYLASE; SULFATED POLYSACCHARIDES; FUCUS-VESICULOSUS; PANCREATIC LIPASE; EDIBLE SEAWEED;
D O I
10.1007/s10811-022-02900-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hypertension, type-2-diabetes (T2D) and obesity are contributory risk factors for the development of metabolic syndrome. Peptides, polyphenols and polysaccharides may inhibit enzymes involved in the disease pathways of this disorder. Peptide hydrolysates (PEP), polyphenol (PP) and polysaccharide (PS) extracts generated from the Australian seaweeds Phyllospora comosa (Labillardiere) C. Agardh, Ecklonia radiata (C. Agardh) J. Agardh, and Ulva ohnoi M. Hiraoka & S. Shimada were screened in vitro for their potential to inhibit enzymes important in the control of diseases associated with metabolic syndrome. These enzymes include angiotensin-I-converting enzyme (ACE-1; EC 3.4.15.1) which affects the development of hypertension in mammals, alpha-amylase (EC 3.2.1.1) and lipase (EC 3.1.1.3) which play a role in the development of T2D and dietary lipid absorption, respectively. The inhibitory activity of each seaweed extract was determined using established in vitro colorimetric methods with mammalian-derived enzymes and their respective substrates. The ACE-1 half-maximal inhibitory (IC50) concentrations of generated bioactive extracts ranged from 167.52 +/- 3.17 mu g mL(-1) (U. ohnoi PEP) to 713.84 +/- 12.45 mu g mL(-1) (E. radiata PS). None of the extracts screened displayed IC50 values comparable to the positive control drug Captopril (8.87 +/- 0.04 mu g mL(-1)). IC50 values determined for extracts that inhibited alpha-amylase ranged from 58.31 +/- 1.41 mu g mL(-1) (P. comosa PP) to 515.24 +/- 10.53 mu g mL(-1) (E. radiata PEP). All PS and PP had significantly lower IC50 values than the alpha-amylase inhibitor control, Acarbose (89.90 +/- 0.15 mu g mL(-1)). Lipase IC50 values determined for extracts ranged from 52.14 +/- 2.77 mu g mL(-1) (P. comosa PP) to 876.30 +/- 34.92 mu g mL(-1) (E. radiata PEP). All PP had significantly lower IC50 values than the lipase inhibitory drug Orlistat (70.83 +/- 0.07 mu g mL(-1)). To the authors' knowledge there are no published values for the inhibitory potential of P. comosa, E. radiata or U. ohnoi extracts against the enzymes ACE-1, alpha-amylase, or lipase. These findings demonstrate the functional food potential of P. comosa, E. radiata and U. ohnoi polyphenols, polysaccharides and peptides.
引用
收藏
页码:893 / 910
页数:18
相关论文
共 50 条
  • [1] In vitro enzyme inhibitory effects of green and brown Australian seaweeds and potential impact on metabolic syndrome
    Emer Shannon
    Michael Conlon
    Maria Hayes
    Journal of Applied Phycology, 2023, 35 : 893 - 910
  • [2] Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases
    Gabbia, Daniela
    De Martin, Sara
    MOLECULES, 2020, 25 (18):
  • [3] Seaweeds as potential therapeutic interventions for the metabolic syndrome
    Senthil Arun Kumar
    Lindsay Brown
    Reviews in Endocrine and Metabolic Disorders, 2013, 14 : 299 - 308
  • [4] Seaweeds as potential therapeutic interventions for the metabolic syndrome
    Kumar, Senthil Arun
    Brown, Lindsay
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2013, 14 (03): : 299 - 308
  • [5] In vitro anticancer potential of laminarin and fucoidan from Brown seaweeds
    Sanniyasi, Elumalai
    Gopal, Rajesh Kanna
    Damodharan, Rajesh
    Arumugam, Arthi
    Sampath Kumar, Madhumitha
    Senthilkumar, Nandhini
    Anbalagan, Monisha
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] In vitro anticancer potential of laminarin and fucoidan from Brown seaweeds
    Elumalai Sanniyasi
    Rajesh Kanna Gopal
    Rajesh Damodharan
    Arthi Arumugam
    Madhumitha Sampath Kumar
    Nandhini Senthilkumar
    Monisha Anbalagan
    Scientific Reports, 13
  • [7] Bioactive potential and possible health effects of edible brown seaweeds
    Gupta, Shilpi
    Abu-Ghannam, Nissreen
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2011, 22 (06) : 315 - 326
  • [8] In Vitro Enzyme Inhibitory Properties, Secondary Metabolite Profiles and Multivariate Analysis of Five Seaweeds
    Mahomoodally, Mohamad Fawzi
    Sadeer, Nabeelah Bibi
    Zengin, Gokhan
    Cziaky, Zoltan
    Jeko, Jozsef
    Diuzheva, Alina
    Sinan, Kouadio Ibrahime
    Palaniveloo, Kishneth
    Kim, Doo Hwan
    Rengasamy, Kannan R. R.
    MARINE DRUGS, 2020, 18 (04)
  • [9] In vitro enzyme inhibitory properties, antioxidant activities, and phytochemical fingerprints of five Moroccan seaweeds
    Grina, Fatiha
    Ullah, Zain
    Kaplaner, Erhan
    Moujahid, Abderrahman
    Eddoha, Rabiaa
    Nasser, Boubker
    Terzioglu, Pinar
    Yilmaz, Mustafa Abdullah
    Ertas, Abdulselam
    Ozturk, Mehmet
    Essamadi, Abdelkhalid
    SOUTH AFRICAN JOURNAL OF BOTANY, 2020, 128 : 152 - 160
  • [10] Impact of Enzyme- and Ultrasound-Assisted Extraction Methods on Biological Properties of Red, Brown, and Green Seaweeds from the Central West Coast of Portugal
    Rodrigues, Dina
    Sousa, Sergio
    Silva, Aline
    Amorim, Manuela
    Pereira, Leonel
    Rocha-Santos, Teresa A. P.
    Gomes, Ana M. P.
    Duarte, Armando C.
    Freitas, Ana Cristina
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2015, 63 (12) : 3177 - 3188